Advertisements



A blockbuster gene-editing tool has been linked to cancer — here"s how worried you should be

American Cancer Society/Getty Images Bold headlines linking blockbuster gene-editing tool CRISPR to cancer sent stocks in companies trying to bring the technology to medicine tumbling. But scientists who study the technique sa.....»»

Category: topSource: businessinsiderJun 13th, 2018

CRISPR-related stocks sink after report that gene-editing technology might cause cancer

Shares of gene-therapy companies sank in active trade Monday, after a STAT report that editing a cell’s genome with CRISPR/Cas9 technology might cause cancer......»»

Category: topSource: marketwatchJun 11th, 2018

CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing

Don't mess with mother nature.. or crowded longs! Crispr Therapeutics led gene-editing stocks lower after new studies published by Nature Medicine found that cells whose genomes are edited with the CRISPR-Cas9 technology have the po.....»»

Category: blogSource: zerohedgeJun 11th, 2018

Scientists can use CRISPR to edit genes. Should they?

Bill Whitaker reports on the gene-editing tool this week on 60 Minutes. The debate over how to use it is playing out in labs around the world.....»»

Category: topSource: moneycentralApr 30th, 2018

A Third Of The Great Barrier Reef Is Gone—Can Gene Editing Help Preserve The Rest?

By using a tool known as CRISPR-Cas9, scientists may be able to identify corals that are genetically predisposed to survive as the climate changes around them......»»

Category: topSource: newsweekApr 23rd, 2018

Bristol-Myers Posts Data on Empliciti, China Approves Opdivo

Bristol-Myers (BMY) announces positive results on oncology drug Empliciti. The company's blockbuster drug, Opdivo, was also approved in China for lung cancer. Br.....»»

Category: dealsSource: nytJun 18th, 2018

Top Stock Picks for the Week of June 18, 2018

Tracey Ryniec and Kevin Cook look at a big energy explorer and one of the hot gene editing biotechs. Occidental Petroleum OXY is a large cap E&P which also has a chemical business. While it’s considered a more conser.....»»

Category: worldSource: nytJun 18th, 2018

Gene-Editing Selloff Is Overdone

The science-journal studies that ignited a rout in Crispr Therapeutics, Editas Medicine, and other gene-therapy shares look to have been misunderstood......»»

Category: topSource: barronsJun 16th, 2018

Gene-editing recent selloff "overdone," Barron"s says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 16th, 2018

A Cancer Blockbuster Gets Approved in China. Will the Floodgates Now Open?

Chinese drug regulators gave the nod to Bristol-Myers Squibb’s immune therapy star Opdivo. Dozens of companies are hoping they’re next. Bristol-Myers Squ.....»»

Category: europeSource: fortuneJun 15th, 2018

New Prostate Cancer DNA Spit Test Developed by Scientists

The new technique could be an important tool for catching a cancer which can be tough to diagnose......»»

Category: topSource: newsweekJun 12th, 2018

Is CRISPR in Touble After New STAT Report?

Shares of CRISPR Therapeutics tumbled after a report was released that gene-edited cells might cause cancer. The implications of this study could be catastrophic for the company seeing as CRISPR is........»»

Category: blogSource: 247wallstJun 11th, 2018

Crispr-linked stocks slide after studies point to increased cancer risk

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2018

Sangamo Banks On Gene Editing Technology To Scale New Highs

Sangamo Banks On Gene Editing Technology To Scale New Highs.....»»

Category: topSource: seekingalphaJun 7th, 2018

Vertex thesis unchanged by gene editing clinical hold, says Jefferies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 31st, 2018

CRISPR, Vertex say FDA puts brakes on upcoming gene editing trial

Cambridge startup CRISPR Therapeutics and Boston-based Vertex Pharmaceuticals said on Wednesday that the FDA has put on hold a highly anticipated upcoming trial of their experimental gene editing drug for sickle cell disease. CRISPR (Nasdaq: CRIS.....»»

Category: topSource: bizjournalsMay 30th, 2018

The FDA just put a pause on a cutting-edge gene editing trial that hadn"t started yet — and the company"s stock is dropping (CRSP, VRTX)

The FDA just put a pause on a cutting-edge gene editing trial that hadn"t started yet — and the company"s stock is dropping (CRSP, VRTX).....»»

Category: topSource: businessinsiderMay 30th, 2018

Cryptocurrency stunt linked to death on Mt. Everest an ‘act of stupidity’

A promotional-cryptocurrency stunt linked to a Sherpa’s death on Mt. Everest has one expert worried about what could happen to the burgeoning industry’s brand. “The publicity stunt structured the way that it is, is endangering people’s lives,.....»»

Category: topSource: foxnewsMay 29th, 2018

Obesity Linked to 12 Types of Cancer in New Report

Report published at the European Congress on Obesity in Vienna......»»

Category: topSource: newsweekMay 24th, 2018

When working for the US government is a cancer risk

Department of Agriculture workers at its Washington headquarters are worried that going to the office has become hazardous to their health......»»

Category: topSource: moneycentralMay 22nd, 2018

Gene therapy turns people into superheroes on TV. Can it do that in real life too?

Netflix’s “Jessica Jones” was inspired by a real-life genetic editing procedure, but the truth is more complicated than fiction......»»

Category: topSource: marketwatchMay 17th, 2018